MeiRui has established a significant position in the China urology market with its BPH, overactive bladder (OAB) and related urology products and have built a close working relationship with the premier Chinese urology medical association. MeiRui can offer pharmaceutical company products a unique and significant access to this segment of the market. MeiRui is continually seeking license-in pharmaceutical products that could serve the Chinese urology and related markets.

If you have pharmaceutical, medical device or diagnostic product that may be of interest to MeiRui, please email that information to MeiRui's Business Development group.